PAF1C-mediated activation of CDK12/13 kinase activity is critical for CTD phosphorylation and transcript elongation
The transcription cycle is regulated by dynamic changes in RNA polymerase II (RNAPII) C-terminal domain (CTD) phosphorylation, which are crucial for gene expression. However, the mechanisms regulating the transcription-specific cyclin-dependent kinases (CDKs) during the transcription cycle remain poorly understood. Here, we show that human CDK12 co-phosphorylates CTD Serine<sub>2</sub> and Serine<sub>5</sub>. This di-phosphorylated Serine<sub>2</sub>-Serine<sub>5</sub> CTD mark may then act as a precursor for Serine<sub>2</sub> mono-phosphorylated CTD through Serine<sub>5</sub> de-phosphorylation. Notably, CDK12 is specifically regulated by association with the elongation-specific factor PAF1 complex (PAF1C), in which the CDC73 subunit contains a metazoan-specific peptide motif, capable of allosteric CDK12/cyclin K activation. This motif is essential for cell proliferation and required for normal levels of CTD phosphorylation in chromatin, and for transcript elongation, particularly across long human genes. Together, these findings provide insight into the mechanisms governing RNAPII phospho-CTD dynamics that ensure progression through the human transcription cycle.
Authors
- Jesper Q. Svejstrup (ORCID: https://orcid.org/0000-0003-4964-6147)
- Izabela Todorovski (ORCID: https://orcid.org/0000-0002-9488-7508)
- A. Barbara Dirac-Svejstrup (ORCID: https://orcid.org/0000-0003-0341-6944)
- Melvin Noé González (ORCID: https://orcid.org/0000-0003-0943-3278)
- Daniel Blears (ORCID: https://orcid.org/0000-0002-2421-0403)
- David López Martínez (ORCID: https://orcid.org/0000-0001-8764-9029)
- Charlotte Rusimbi (ORCID: https://orcid.org/0009-0002-1500-4648)
- Zhong Han (ORCID: https://orcid.org/0000-0002-8705-1614)
- Nessrine Khallou
Institutions
- University of Copenhagen (DK)
Publication Details
- Journal
- Molecular Cell
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.molcel.2025.04.012
- Citations
- 8
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 6.45
Funders
- Francis Crick Institute
- European Commission
- National Research Foundation
- Danmarks Grundforskningsfond
- Novo Nordisk
- Novo Nordisk Fonden